A Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male Subjects

Clinical trial NCT01325415 · COMPLETED

Trial details

NCT number

NCT01325415

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-04-01

Primary completion

2011-07-01

Enrollment

45

View on ClinicalTrials.gov